Ryuzo Ohno

Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia.

Hitoshi Kiyoi, Tomoki Naoe, Yasuyuki Nakano et al. · PubMed · 1999 · 765 citations

Medicine, Genetics, Oncology +16

High Complete Remission Rate and Promising Outcome by Combination of Imatinib and Chemotherapy for Newly Diagnosed <i>BCR</i>-<i>ABL</i>–Positive Acute Lymphoblastic Leukemia: A Phase II Study by the Japan Adult Leukemia Study Group

Masamitsu Yanada, Jin Takeuchi, Isamu Sugiura et al. · Journal of Clinical Oncology · 2005 · 454 citations · Full text

Medicine, Hematology, Oncology +15

Effect of Granulocyte Colony-Stimulating Factor after Intensive Induction Therapy in Relapsed or Refractory Acute Leukemia

Ryuzo Ohno, Masao Tomonaga, Tohru Kobayashi et al. · New England Journal of Medicine · 1990 · 397 citations · Full text

Medicine, Hematology, Oncology +16

Mechanism of constitutive activation of FLT3 with internal tandem duplication in the juxtamembrane domain

Hitoshi Kiyoi, Ryuzo Ohno, Ryuzo Ueda et al. · Oncogene · 2002 · 283 citations

Life Sciences, Genetics, Molecular Biology +7

Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study

Shigeki Ohtake, Shuichi Miyawaki, Hiroyuki Fujita et al. · Blood · 2010 · 262 citations · Full text

Medicine, Oncology, Pharmacology +15